Medifast (MED) Projected to Post Quarterly Earnings on Tuesday

Medifast (NYSE:MED - Get Free Report) is expected to issue its quarterly earnings data after the market closes on Tuesday, February 18th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $114.25 million for the quarter. Parties that are interested in participating in the company's conference call can do so using this link.

Medifast Stock Performance

MED stock traded up $0.16 during trading on Friday, reaching $16.19. 235,933 shares of the stock were exchanged, compared to its average volume of 210,034. Medifast has a twelve month low of $14.76 and a twelve month high of $52.96. The company has a market capitalization of $177.10 million, a P/E ratio of 24.53 and a beta of 1.14. The stock has a 50 day simple moving average of $16.78 and a 200-day simple moving average of $18.17. The company has a current ratio of 3.11, a quick ratio of 2.55 and a debt-to-equity ratio of 0.06.

Analyst Upgrades and Downgrades

Separately, DA Davidson raised Medifast from an "underperform" rating to a "neutral" rating and lifted their price objective for the company from $16.50 to $17.00 in a report on Tuesday, November 5th.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.